SE8203953D0 - Pharmaceutical mixture - Google Patents

Pharmaceutical mixture

Info

Publication number
SE8203953D0
SE8203953D0 SE8203953A SE8203953A SE8203953D0 SE 8203953 D0 SE8203953 D0 SE 8203953D0 SE 8203953 A SE8203953 A SE 8203953A SE 8203953 A SE8203953 A SE 8203953A SE 8203953 D0 SE8203953 D0 SE 8203953D0
Authority
SE
Sweden
Prior art keywords
prepn
iii
esp
cpd
polyhydroxy
Prior art date
Application number
SE8203953A
Other languages
English (en)
Swedish (sv)
Inventor
K J Mattsson
R I Sjoqvist
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Priority to SE8203953A priority Critical patent/SE8203953D0/xx
Publication of SE8203953D0 publication Critical patent/SE8203953D0/xx
Priority to IL68779A priority patent/IL68779A0/xx
Priority to CA000429157A priority patent/CA1214726A/en
Priority to ZA833931A priority patent/ZA833931B/xx
Priority to AT83850147T priority patent/ATE59286T1/de
Priority to EP83850147A priority patent/EP0101418B1/en
Priority to DE8383850147T priority patent/DE3382086D1/de
Priority to DK272383A priority patent/DK161365C/da
Priority to FI832197A priority patent/FI85213C/fi
Priority to BG61387A priority patent/BG51341A3/xx
Priority to NZ204639A priority patent/NZ204639A/en
Priority to PH29088A priority patent/PH21911A/en
Priority to AU15943/83A priority patent/AU561954B2/en
Priority to AR293393A priority patent/AR231075A1/es
Priority to IE1462/83A priority patent/IE55204B1/en
Priority to CS834636A priority patent/CS257769B2/cs
Priority to ES523536A priority patent/ES523536A0/es
Priority to HU832225A priority patent/HU189300B/hu
Priority to JP58111990A priority patent/JPS5916822A/ja
Priority to DD83252303A priority patent/DD209971A5/de
Priority to GR71768A priority patent/GR78604B/el
Priority to PT76919A priority patent/PT76919B/pt
Priority to NO832293A priority patent/NO168745C/no
Priority to GB08317071A priority patent/GB2122490B/en
Priority to SU833607650A priority patent/SU1722207A3/ru
Priority to KR1019830002854A priority patent/KR910000028B1/ko
Priority to IS2824A priority patent/IS1325B6/is
Priority to US06/815,125 priority patent/US4994260A/en
Priority to HK987/86A priority patent/HK98786A/xx
Priority to MY292/87A priority patent/MY8700292A/xx
Priority to CY1468A priority patent/CY1468A/xx
Priority to LV930693A priority patent/LV5391A3/xx
Priority to LTRP946A priority patent/LT2252B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8203953A 1982-05-28 1982-06-24 Pharmaceutical mixture SE8203953D0 (sv)

Priority Applications (33)

Application Number Priority Date Filing Date Title
SE8203953A SE8203953D0 (sv) 1982-06-24 1982-06-24 Pharmaceutical mixture
IL68779A IL68779A0 (en) 1982-06-24 1983-05-25 Pharmaceutical mixture with controlled release of active substance
CA000429157A CA1214726A (en) 1982-06-24 1983-05-30 Pharmaceutical mixture
ZA833931A ZA833931B (en) 1982-06-24 1983-05-30 Pharmaceutical mixture
AT83850147T ATE59286T1 (de) 1982-06-24 1983-05-31 Pharmazeutische mixtur.
EP83850147A EP0101418B1 (en) 1982-06-24 1983-05-31 Pharmaceutical mixture
DE8383850147T DE3382086D1 (de) 1982-06-24 1983-05-31 Pharmazeutische mixtur.
DK272383A DK161365C (da) 1982-06-24 1983-06-14 Flydende farmaceutisk praeparat til oral indgivelse med kontrolleret frigivelse og god stabilitet, samt fremgangsmaade til fremstilling heraf
FI832197A FI85213C (fi) 1982-06-24 1983-06-16 Foerfarande foer framstaellning av en farmaceutisk beredning.
BG61387A BG51341A3 (en) 1982-06-24 1983-06-20 Method for the preparation of pharmaceutical mixture
NZ204639A NZ204639A (en) 1982-06-24 1983-06-20 The use of a carbohydrate as a slow release agent for an encapsulated active pharmaceutical substance
PH29088A PH21911A (en) 1982-06-24 1983-06-20 Pharmaceutical mixture
AU15943/83A AU561954B2 (en) 1982-06-24 1983-06-20 Dispersion of capsules for slow release
AR293393A AR231075A1 (es) 1982-06-24 1983-06-21 Procedimiento para preparar un preparado de mezcla farmaceutica
IE1462/83A IE55204B1 (en) 1982-06-24 1983-06-22 Pharmaceutical mixture
CS834636A CS257769B2 (en) 1982-06-24 1983-06-23 Method of oral pharmaceutical preparations production
ES523536A ES523536A0 (es) 1982-06-24 1983-06-23 "un metodo para preparar una mezcla farmaceutica con liberacion controlada de sustancia activa"
SU833607650A SU1722207A3 (ru) 1982-06-24 1983-06-23 Способ изготовлени средства дл перорального введени
HU832225A HU189300B (en) 1982-06-24 1983-06-23 Process for preparing oral pharmaceutical composition of improved taste
JP58111990A JPS5916822A (ja) 1982-06-24 1983-06-23 薬学的懸濁液製剤
DD83252303A DD209971A5 (de) 1982-06-24 1983-06-23 Verfahren zur herstellung eines pharmazeutischen praeparates
GR71768A GR78604B (fi) 1982-06-24 1983-06-23
PT76919A PT76919B (en) 1982-06-24 1983-06-23 Process for preparing pharmaceutical mixture compositions with controlled release of active substance
NO832293A NO168745C (no) 1982-06-24 1983-06-23 Fremgangsmaate for fremstilling av farmasoeytisk blandingspreparat
GB08317071A GB2122490B (en) 1982-06-24 1983-06-23 Controlled release formulation
KR1019830002854A KR910000028B1 (ko) 1982-06-24 1983-06-24 제약 혼합제의 제조방법
IS2824A IS1325B6 (is) 1982-06-24 1983-06-24 Lyfjablanda
US06/815,125 US4994260A (en) 1982-05-28 1985-12-30 Pharmaceutical mixture
HK987/86A HK98786A (en) 1982-06-24 1986-12-18 Pharmaceutical mixture
MY292/87A MY8700292A (en) 1982-06-24 1987-12-30 Pharmaceutical mixture
CY1468A CY1468A (en) 1982-06-24 1989-07-21 Pharmaceutical mixture
LV930693A LV5391A3 (lv) 1982-06-24 1993-06-28 Panemiens perorali ievadama arstniecibas lidzekla izgatavosanai
LTRP946A LT2252B (lt) 1982-06-24 1993-09-06 Peroralinio vaisto gamybos budas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8203953A SE8203953D0 (sv) 1982-06-24 1982-06-24 Pharmaceutical mixture

Publications (1)

Publication Number Publication Date
SE8203953D0 true SE8203953D0 (sv) 1982-06-24

Family

ID=20347191

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8203953A SE8203953D0 (sv) 1982-05-28 1982-06-24 Pharmaceutical mixture

Country Status (29)

Country Link
EP (1) EP0101418B1 (fi)
JP (1) JPS5916822A (fi)
KR (1) KR910000028B1 (fi)
AR (1) AR231075A1 (fi)
AT (1) ATE59286T1 (fi)
AU (1) AU561954B2 (fi)
BG (1) BG51341A3 (fi)
CA (1) CA1214726A (fi)
CS (1) CS257769B2 (fi)
CY (1) CY1468A (fi)
DD (1) DD209971A5 (fi)
DE (1) DE3382086D1 (fi)
DK (1) DK161365C (fi)
ES (1) ES523536A0 (fi)
FI (1) FI85213C (fi)
GB (1) GB2122490B (fi)
GR (1) GR78604B (fi)
HK (1) HK98786A (fi)
HU (1) HU189300B (fi)
IE (1) IE55204B1 (fi)
IS (1) IS1325B6 (fi)
MY (1) MY8700292A (fi)
NO (1) NO168745C (fi)
NZ (1) NZ204639A (fi)
PH (1) PH21911A (fi)
PT (1) PT76919B (fi)
SE (1) SE8203953D0 (fi)
SU (1) SU1722207A3 (fi)
ZA (1) ZA833931B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729927B2 (ja) * 1983-04-09 1995-04-05 日研化学株式会社 テオフィリン徐放性製剤
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
IT1183575B (it) * 1985-05-08 1987-10-22 Eurand Spa Formulazione deodorando ad effetto modulante sulla trfaspirazione
NL8503539A (nl) * 1986-01-02 1987-07-16 Warner Lambert Co Sucrose-vrije preparaten.
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
SE8605515D0 (sv) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A liquid dosage form for oral administration of a pharmaceutically active substance
US4874613A (en) * 1987-03-06 1989-10-17 Baker Cummins Pharmaceuticals, Inc. Taste concealing pharmaceutical dosage unit
US5427935A (en) * 1987-07-24 1995-06-27 The Regents Of The University Of Michigan Hybrid membrane bead and process for encapsulating materials in semi-permeable hybrid membranes
SE463542B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer instanticerbar produkt samt foerfarande foer dess framstaellning
US5064650A (en) * 1988-04-19 1991-11-12 Southwest Research Institute Controlled-release salt sensitive capsule for oral use and adhesive system
WO1989010117A1 (en) * 1988-04-19 1989-11-02 Southwest Research Institute Controlled release of active ingredients from capsules having a salt sensitive shell material
FR2653337B1 (fr) * 1989-10-23 1992-02-07 Dow Corning Sa Element a liberation prolongee et procede pour le fabriquer.
CA2068402C (en) * 1991-06-14 1998-09-22 Michael R. Hoy Taste mask coatings for preparation of chewable pharmaceutical tablets
US5364634A (en) * 1991-11-08 1994-11-15 Southwest Research Institute Controlled-release PH sensitive capsule and adhesive system and method
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP3265680B2 (ja) * 1992-03-12 2002-03-11 大正製薬株式会社 経口製剤用組成物
DE4312656C2 (de) * 1993-04-19 1996-01-25 Beiersdorf Ag Kühlend wirkende kosmetische oder dermatologische Zusammensetzungen
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
ATE352289T1 (de) * 1995-05-02 2007-02-15 Taisho Pharmaceutical Co Ltd Mittel zur oralen verabreichung
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (fi) * 1961-01-31
US3689654A (en) * 1970-09-14 1972-09-05 Morton Norwich Products Inc Pharmaceutical compositions
ES434971A1 (es) * 1974-02-22 1977-05-16 Wellcome Found Metodo para producir un preparado farmaceutico que comprendeuna solucin de digoxina en una envolvente de capsula solu- ble.
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4321253A (en) * 1980-08-22 1982-03-23 Beatty Morgan L Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
JPS57209223A (en) * 1981-06-19 1982-12-22 Tanabe Seiyaku Co Ltd Microcapsule for intracranial anti hypotension and its production

Also Published As

Publication number Publication date
AR231075A1 (es) 1984-09-28
DK161365B (da) 1991-07-01
IE831462L (en) 1983-12-24
NO832293L (no) 1983-12-27
FI832197A0 (fi) 1983-06-16
ES8403720A1 (es) 1984-04-01
PT76919A (en) 1983-07-01
HU189300B (en) 1986-06-30
KR840005024A (ko) 1984-11-03
DD209971A5 (de) 1984-05-30
ZA833931B (en) 1984-07-25
HK98786A (en) 1986-12-24
DK272383D0 (da) 1983-06-14
NO168745B (no) 1991-12-23
GB8317071D0 (en) 1983-07-27
CS463683A2 (en) 1987-11-12
EP0101418A3 (en) 1984-11-14
FI85213B (fi) 1991-12-13
GR78604B (fi) 1984-09-27
JPH0559089B2 (fi) 1993-08-30
IE55204B1 (en) 1990-07-04
EP0101418A2 (en) 1984-02-22
GB2122490B (en) 1986-04-03
AU561954B2 (en) 1987-05-21
PT76919B (en) 1986-04-09
DK161365C (da) 1991-12-09
NZ204639A (en) 1986-01-24
CA1214726A (en) 1986-12-02
EP0101418B1 (en) 1990-12-27
DK272383A (da) 1983-12-25
MY8700292A (en) 1987-12-31
FI85213C (fi) 1992-03-25
CY1468A (en) 1989-07-21
BG51341A3 (en) 1993-04-15
AU1594383A (en) 1984-01-05
PH21911A (en) 1988-04-08
FI832197L (fi) 1983-12-25
GB2122490A (en) 1984-01-18
JPS5916822A (ja) 1984-01-28
ES523536A0 (es) 1984-04-01
IS2824A7 (is) 1983-12-25
ATE59286T1 (de) 1991-01-15
CS257769B2 (en) 1988-06-15
KR910000028B1 (ko) 1991-01-19
DE3382086D1 (de) 1991-02-07
IS1325B6 (is) 1988-08-03
SU1722207A3 (ru) 1992-03-23
NO168745C (no) 1992-04-01

Similar Documents

Publication Publication Date Title
SE8203953D0 (sv) Pharmaceutical mixture
DK567088A (da) Indretning til transdermal laegemiddelindgift
MX10086A (es) Un sistema para la administracion de substancias activas no solubles en agua y procedimiento para su preparacion.
NO953189D0 (no) Vandig legemiddelpreparat med evne til reversibel varmeherdende gelering
DK280884A (da) Galeniske praeparatformer for orale antidiabetica og fremgangsmaade til deres fremstilling
NO156275C (no) Fremgangsmaate for fremstilling av kapsler inneholdende et toert, pulverformet allergenpreparat.
ES509647A0 (es) Procedimiento para preparar una polilactida.
MX169322B (es) Formulacion farmaceutica de liberacion prolongada
DK360489A (da) Produkter indeholdende mikro- eller nanopartikler samt fremgangsmaade til deres fremstilling
ES487151A1 (es) Procedimiento de preparacion de nuevas formas galenicas de administracion de medicamentos por via oral, con liberacion programada
ATA84882A (de) Therapeutisches abgabesystem zur verabreichung eines wirkstoffes durch die haut
DE3880593D1 (de) Arzneizubereitungen mit retardierter wirkstofffreisetzung.
KR890700375A (ko) 피부에 유효약제를 조절하여 투여하는 유효약제-함유 플래스터
NZ234802A (en) Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
NL151693B (nl) Werkwijze voor het bereiden van een geneesmiddel met een bronchospasmolytische werking dat een derivaat van 2-amino-1-(3,5-dihydroxyfenyl)ethanol bevat en het onder toepassing van deze werkwijze verkregen gevormde geneesmiddel met een bronchospasmolytische werking en werkwijze voor het bereiden van een geneeskrachtig 2-amino-1-(3,5-dihydroxyfenyl)ethanolderivaat, dat als actief bestanddeel in zo'n geneesmiddel wordt toegepast.
IE45054L (en) Veterinary composition
DK0469064T3 (da) Anvendelse af C-20- til C-26-alifatiske alkoholer til fremstilling af et lægemiddel til behandling af virusinfektioner
McKellar et al. Comparison of ivermectin, oxfendazole and levamisole for use as anthelmintics during the periparturient period in sheep
JPS579711A (en) Preparation of prolonged release type complex
FR2786699B1 (fr) Medicament destine notamment a prevenir ou traiter les dysfonctions sexuelles
JPS643123A (en) Remedy for skin inflammation
Radó et al. Concentrating power of the kidney after five years of pitressin-tannate therapy in a patient with diabetes insipidus untreated for 13 years.(Investigations during intravenous administration of hypertonic sodium chloride, lysine-vasopressin, clopamide and furosemide)
SU575096A1 (ru) Способ стимул ции родовой де тельности
Magee The effect of therapeutic ultrasound on the level of blood sugar in the human body
DE3688355D1 (de) Fester koerper mit ueberzogenem kern.